The applicant will apply advanced programming and analytical skills to create and manage analytical datasets from diverse sources, including healthcare claims, clinical trials, observational cohorts, surveys, and electronic health records. Responsibilities include data cleaning, manipulation, standardization of outcome measures, and construction of analytic variables. The position conducts descriptive and advanced statistical analyses using SAS, R, SPSS, STATA or other appropriate software, including risk modeling and applications of statistical, machine learning, and artificial intelligence approaches.
Additional responsibilities include preparing graphs, tables, and analytic reports; interpreting and presenting findings; and supporting regulatory and sponsor reporting requirements (e.g., DSMB, NIH, ClinicalTrials.gov). The role assists with power calculations and drafting methods sections for grant proposals, manuscripts, and abstracts, and participates in literature review of biomedical and clinical research.
The biostatistician oversees data management activities using REDCap and Qualtrics, coordinates REDCap Users Group meetings, and serves as a technical resource for data capture platforms and statistical software. The position collaborates closely with research project managers to coordinate statistical activities and, as demands expand, contributes to the development of a more formal Data Management and Statistical Unit. Ongoing mentorship and methodological guidance are provided by PhD-level epidemiologists and MD epidemiologists to ensure rigorous and optimal analytic approaches.
Job Responsibilities
- Compute and analyze data, using statistical formulas and computers or calculators
- Check source data to verify completeness and accuracy.
- Enter data into computers for use in analyses or reports.
- Compile reports, charts, or graphs that describe and interpret findings of analyses.
- Participate in the publication of data or information.
- Other duties and responsibilities as assigned
*Position contingent upon continued funding*
